Dr. Nandagopal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4501 Empire Ct
Fredericksburg, VA 22408Phone+1 540-371-0079Fax+1 540-656-2653
Education & Training
- University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- University of Alabama at BirminghamCertificate, Clinical and Translational Science, 2017
- University of Alabama at BirminghamCertificate, Clinical Investigator Training Program, 2017
- Wayne State University School of MedicineResidency, Internal Medicine, 2010 - 2013
- OtherClass of 2008
Certifications & Licensure
- VA State Medical License 2022 - 2026
- AL State Medical License 2015 - 2022
- MI State Medical License 2010 - 2016
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsComprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.Raquel Zimmerman, Mehmet A Bilen, Elisabeth I Heath, Lakshminarayanan Nandagopal, Umang Swami
The Oncologist. 2022-10-01 - 145 citationsNCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.Thomas W Flaig, Philippe E Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs
Journal of the National Comprehensive Cancer Network. 2022-08-01 - 3 citationsMulti-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.Meredith N Freeman, Albert Jang, Jason Zhu, Farhad Sanati, Lakshminarayanan Nandagopal
The Oncologist. 2022-03-11
Journal Articles
- Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell CarcinomaNandagopal L, Naik G, Sonpavde G, Current treatment options in Oncology, 1/18/2018
- Timing of androgen deprivation therapy in prostate cancerNandagopal L, Lancet Oncology, 1/1/2017
- Treatment approaches of hard-to-treat non-Hodgkin lymphomasNandagopal L, Mehta AK, Expert Review of Hematology, 1/1/2016
- Join now to see all
Abstracts/Posters
- Improving hepatitis B screening prior to Rituximab-based treatments at a multi-specialty urban VA hospitalNandagopal L, Paluri R, Gleaton B, Nabell L, ASCO Quality Care Symposium, Orlando, FL, 1/1/2017
- Factors affecting outcomes in gall bladder cancer � a single institution retrospective analysisNandagopal L, Heslin M, Porterfield J R, Javob R, Li P, Posey J, Paluri R, AACR annual meeting, 1/1/2017
- The diagnostic and therapeutic challenges in an unusual case of Stills disease and Systemic lupus erythematosus overlap - A Spectrum of Auto-inflammatory Syndrome?Nandagopal L, Itikyala S, Neill D, Nagori K,Ramchandren R, Krishnamurthy V, Sagar H, York R, Venkatram M, ACP Associates Day, MI, 1/1/2014
- Join now to see all
Lectures
- Urothelial carcinomaUniversity of Alabama at Birmingham, Birmingham, AL - 1/1/2018
- Molecular advances in prostate cancerUniversity of Alabama at Birmingham, Birmingham, AL - 1/1/2018
- Prostate cancer 101- a primer for Fellows1/1/2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: